Abstract
Earlier observations indicate that free heme is selectively toxic to cells lacking heme oxygenase-1 (HO-1) but how this enzyme prevents heme toxicity remains unexplained. Here, using A549 (human lung cancer) and immortalized human bronchial epithelial cells incubated with exogenous heme, we find knock-down of HO-1 using siRNA does promote the accumulation of cell-associated heme and heme-induced cell death. However, it appears that the toxic effects of heme are exerted by “loose” (probably intralysosomal) iron because cytotoxic effects of heme are lessened by pre-incubation of HO-1 deficient cells with desferrioxamine (which localizes preferentially in the lysosomal compartment). Desferrioxamine also decreases lysosomal rupture promoted by intracellularly generated hydrogen peroxide. Supporting the importance of endogenous oxidant production, both chemical and siRNA inhibition of catalase activity predisposes HO-1 deficient cells to heme-mediated killing. Importantly, it appears that HO-1 deficiency somehow blocks the induction of ferritin; control cells exposed to heme show ~10-fold increases in ferritin heavy chain expression whereas in heme-exposed HO-1 deficient cells ferritin expression is unchanged. Finally, overexpression of ferritin H chain in HO-1 deficient cells completely prevents heme-induced cytotoxicity. Although two other products of HO-1 activity–CO and bilirubin–have been invoked to explain HO-1-mediated cytoprotection, we conclude that, at least in this experimental system, HO-1 activity triggers the induction of ferritin and the latter is actually responsible for the cytoprotective effects of HO-1 activity.
Highlights
The impetus for the present investigations was a paper published over a decade ago by Yachie et al [1] on the first human with heme oxygenase-1 (HO-1) deficiency
To ensure that the effects of HO-1KO were not restricted to A549 cells, we conducted similar experiments with immortalized human bronchial epithelial cells
Contrary to the earlier report by Fortes et al [2], we find no evidence of transcriptional upregulation of TNFalpha mRNA following heme exposure of either control or HO-1KO A549 cells whereas cells exposed to LPS alone showed substantial up-regulation of tumor necrosis factor (TNF)-alpha mRNA
Summary
The impetus for the present investigations was a paper published over a decade ago by Yachie et al [1] on the first human with heme oxygenase-1 (HO-1) deficiency. In their description of this unique patient, the authors reported a phenomenon that was difficult to explain. When they challenged an Epstein-Barr virus-transformed lymphoblastoid cell line from this patient with exogenous heme (50–200 μM), over 24 hours most or most of these cells died. This, despite the fact that in neither case was there a significant change in the amounts of heme in the culture medium over the incubation period
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have